Cargando…

Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma

BACKGROUND: Papillary thyroid carcinoma (PTC) has a favorable prognosis following one-stage surgical therapy, whereas two-stage resections bear the risk of increased morbidity and possibly impaired prognosis. To further elucidate the value of surgical re-exploration in PTC, a retrospective study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Baerbock, Nenia, Mittelstädt, Anke, Jähne, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817731/
https://www.ncbi.nlm.nih.gov/pubmed/31709300
http://dx.doi.org/10.1515/iss-2018-0023
_version_ 1783463485724688384
author Baerbock, Nenia
Mittelstädt, Anke
Jähne, Joachim
author_facet Baerbock, Nenia
Mittelstädt, Anke
Jähne, Joachim
author_sort Baerbock, Nenia
collection PubMed
description BACKGROUND: Papillary thyroid carcinoma (PTC) has a favorable prognosis following one-stage surgical therapy, whereas two-stage resections bear the risk of increased morbidity and possibly impaired prognosis. To further elucidate the value of surgical re-exploration in PTC, a retrospective study was performed. METHODS: The study involved 187 patients with PTC who underwent total thyroidectomy with central lymph node dissection between 2001 and 2011. The number of two-stage surgeries, the rates of recurrent laryngeal nerve paralysis (RLNP) as well as hypocalcemia, and the long-term survival were assessed. RESULTS: Two-stage surgeries were performed in 43%. No statistically significant difference was seen between the one- and two-stage resection groups regarding the rate of RLNP (transient 5.6% vs. 6.3%, permanent 2.6% vs. 0%) nor for hypocalcemia (transient 25.2% vs. 18.8%, permanent 14.0% vs. 22.5%). The 10-year recurrence-free survival was 95.5% and the 10-year disease-specific survival was 98.9% with no difference between groups. CONCLUSION: Even though two-stage surgeries do not lead to a higher incidence of RLNP and hypocalcemia, optimal preoperative and intraoperative diagnostics have to be carried out to reduce the amount of completion surgeries.
format Online
Article
Text
id pubmed-6817731
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-68177312019-11-08 Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma Baerbock, Nenia Mittelstädt, Anke Jähne, Joachim Innov Surg Sci Original Articles BACKGROUND: Papillary thyroid carcinoma (PTC) has a favorable prognosis following one-stage surgical therapy, whereas two-stage resections bear the risk of increased morbidity and possibly impaired prognosis. To further elucidate the value of surgical re-exploration in PTC, a retrospective study was performed. METHODS: The study involved 187 patients with PTC who underwent total thyroidectomy with central lymph node dissection between 2001 and 2011. The number of two-stage surgeries, the rates of recurrent laryngeal nerve paralysis (RLNP) as well as hypocalcemia, and the long-term survival were assessed. RESULTS: Two-stage surgeries were performed in 43%. No statistically significant difference was seen between the one- and two-stage resection groups regarding the rate of RLNP (transient 5.6% vs. 6.3%, permanent 2.6% vs. 0%) nor for hypocalcemia (transient 25.2% vs. 18.8%, permanent 14.0% vs. 22.5%). The 10-year recurrence-free survival was 95.5% and the 10-year disease-specific survival was 98.9% with no difference between groups. CONCLUSION: Even though two-stage surgeries do not lead to a higher incidence of RLNP and hypocalcemia, optimal preoperative and intraoperative diagnostics have to be carried out to reduce the amount of completion surgeries. De Gruyter 2019-03-27 /pmc/articles/PMC6817731/ /pubmed/31709300 http://dx.doi.org/10.1515/iss-2018-0023 Text en ©2019 Baerbock N., et al., published by De Gruyter, Berlin/Boston http://creativecommons.org/licenses/by/4.0 This work is licensed under the Creative Commons Attribution 4.0 Public License.
spellingShingle Original Articles
Baerbock, Nenia
Mittelstädt, Anke
Jähne, Joachim
Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma
title Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma
title_full Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma
title_fullStr Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma
title_full_unstemmed Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma
title_short Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma
title_sort morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817731/
https://www.ncbi.nlm.nih.gov/pubmed/31709300
http://dx.doi.org/10.1515/iss-2018-0023
work_keys_str_mv AT baerbocknenia morbidityandlongtermsurvivalinpatientswithcervicalreexplorationforpapillarythyroidcarcinoma
AT mittelstadtanke morbidityandlongtermsurvivalinpatientswithcervicalreexplorationforpapillarythyroidcarcinoma
AT jahnejoachim morbidityandlongtermsurvivalinpatientswithcervicalreexplorationforpapillarythyroidcarcinoma